GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

In this interview, News Medical speaks with Dr Bryony Henderson, Medical Director for the UK and US at MedExpress, about the evolving role of GLP‑1 agonists in obesity care and the future of metabolic ...

GLP-1 weight-loss drugs are in the news because so many people are using them to treat obesity and diabetes. With so many ...

If you live with obesity or type 2 diabetes, your doctor may have talked to you about GIP/GLP-1 agonist medications, such as tirzepatide (Mounjaro or Zepbound), which may help you lose weight. And ...

Pharmaceutical vending machine at an airport. Image by Tim Sandle. Pharmaceutical vending machine at an airport. Image by Tim Sandle. Can a new discovery usher in a new generation of GLP-1 peptides – ...

Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...

Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how to protect your strength while reaping the benefits. Study: Glucagon-like peptide-1 receptor ...

SAN DIEGO — New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings ...

GLP-1RAs improved RA disease activity, pain scores, weight, cholesterol, and HbA1c levels in patients with a BMI ≥27. Nearly one-third of patients discontinued GLP-1RA therapy due to gastrointestinal ...